Bionexus Gene Lab Corp. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 15, 2024).

The article discusses Bionexus Gene Lab Corp.'s SEC Form 10-Q filing, which was posted on November 15, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. Bionexus Gene Lab Corp. is classified under the SIC code 8071 for Medical Laboratories, with contact information located in Kuala Lumpur. The filing is a formal document submitted to the SEC by publicly-traded companies, offering transparency and accountability to investors and stakeholders. [Extracted from the article]